RM LAW Announces Investigation of Pardes Biosciences, Inc.

BERWYN, Pa., Jan. 30, 2023 /PRNewswire/ -- RM LAW, P.C. is investigating potential claims against the board of directors of Pardes Biosciences, Inc. ("Pardes" or the "Company") (NASDAQ: PRDS) investors concerning the Company's possible violations of the federal securities laws.

If you own shares of Pardes and would like to learn more about this class action or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (844) 291-9299 or to sign up online, click here. You may also email Mr. Maniskas at [email protected]. 

RM Law is investigating potential violations of law in connection with the following special purpose acquisition company ("SPAC"): Pardes Biosciences, Inc. f/k/a FS Development Corp. II (NASDAQ: PRDS).

For more information regarding this, please contact RM LAW, P.C. (Richard A. Maniskas, Esquire) toll-free at (844) 291-9299 or by email at [email protected] or click here. For more information about class action cases in general or to learn more about RM LAW, P.C. please visit our website by clicking here. 

CONTACT:              RM LAW, P.C.
                                Richard A. Maniskas, Esquire
                                1055 Westlakes Dr., Ste. 300
                                Berwyn, PA 19312
                                484-324-6800
                                844-291-9299
                                [email protected]

SOURCE RM LAW, P.C.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED